2019
- Codagenix Inc. Announces Award of $1M US Army Contract for Continued Development of Contemporary, Balanced Dengue Vaccine
- Codagenix: Combating Deadly Diseases with a Fast Track to Vaccine Development Wired
2017
- RSV vaccine player Codagenix snags $3M in public and private investment FiercePharma
- Demonstration of Multi-Season Efficacy and Immunogenicity of CodaVax Intranasal Influenza Vaccine